technetium tc 99m (sn)methylenediphosphonate and Prostatic Neoplasms

technetium tc 99m (sn)methylenediphosphonate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conolly, M; Ding, C; Horak, I; Imbriaco, M; Kelly, WK; Kremer, A; Larson, SM; Ouyang, P; Sabbatini, P; Scher, HI; Sun, M; Yeung, H; Zhang, ZF	1

Trials

1 trial(s) available for technetium tc 99m (sn)methylenediphosphonate and Prostatic Neoplasms

Article	Year
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Algorithms; Androgens; Bone Neoplasms; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Survival Analysis; Technetium Tc 99m Medronate	1999

Article

Year

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3

Topics: Aged; Aged, 80 and over; Algorithms; Androgens; Bone Neoplasms; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Survival Analysis; Technetium Tc 99m Medronate

1999